BRPI0913216A2 - uso de um herpesvírus recombinante de perus, e, herpesvírus recombinante de perus. - Google Patents

uso de um herpesvírus recombinante de perus, e, herpesvírus recombinante de perus.

Info

Publication number
BRPI0913216A2
BRPI0913216A2 BRPI0913216A BRPI0913216A BRPI0913216A2 BR PI0913216 A2 BRPI0913216 A2 BR PI0913216A2 BR PI0913216 A BRPI0913216 A BR PI0913216A BR PI0913216 A BRPI0913216 A BR PI0913216A BR PI0913216 A2 BRPI0913216 A2 BR PI0913216A2
Authority
BR
Brazil
Prior art keywords
turkeys
recombinant herpesvirus
herpesvirus
recombinant
Prior art date
Application number
BRPI0913216A
Other languages
English (en)
Inventor
Virgil Elisabeth Joseph Caspar Schijns
Wilhelmus Gerardus Johannes Degen
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BRPI0913216A2 publication Critical patent/BRPI0913216A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0913216A 2008-06-23 2009-06-22 uso de um herpesvírus recombinante de perus, e, herpesvírus recombinante de perus. BRPI0913216A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08158788 2008-06-23
US7507908P 2008-06-24 2008-06-24
EP08158920 2008-06-25
PCT/EP2009/057746 WO2009156367A1 (en) 2008-06-23 2009-06-22 Recombinant herpesvirus of turkeys encoding for interleukin-12

Publications (1)

Publication Number Publication Date
BRPI0913216A2 true BRPI0913216A2 (pt) 2016-01-19

Family

ID=41009876

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913216A BRPI0913216A2 (pt) 2008-06-23 2009-06-22 uso de um herpesvírus recombinante de perus, e, herpesvírus recombinante de perus.

Country Status (7)

Country Link
US (1) US20110110887A1 (pt)
EP (1) EP2291397A1 (pt)
JP (1) JP2011525519A (pt)
CN (1) CN102056941A (pt)
BR (1) BRPI0913216A2 (pt)
MX (1) MX2010013693A (pt)
WO (1) WO2009156367A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2629794B1 (en) 2010-10-18 2017-06-07 Intervet International B.V. Herpesvirus of turkeys vectored vaccine against avian influenza in poultry
WO2013057235A1 (en) 2011-10-21 2013-04-25 Intervet International B.V. Recombinant nonpathogenic mdv vector providing multivalent immunity
AR103245A1 (es) 2014-12-24 2017-04-26 Intervet Int Bv Vacuna vectorial basada en hvt (herpes virus de los pavos) frente a nd (enfermedad de newcastle) - ibd (enfermedad de gumboro) mejorada
MX2020006343A (es) 2017-12-20 2020-09-03 Intervet Int Bv Diluyente mejorado para vacuna de herpesvirus alfa asociado con celulas.
BR112022021733A2 (pt) 2020-04-27 2022-12-06 Nestle Sa Método para a produção de produtos semelhantes a leite
CN115461119A (zh) 2020-04-27 2022-12-09 雀巢产品有限公司 用于生产乳样产物的方法
MA58717A1 (fr) 2020-06-17 2023-06-28 Boehringer Ingelheim Vetmedica Gmbh Vecteurs hvt recombinants exprimant l'hémagglutinine de la grippe et compositions immunogènes, et leur fabrication et leurs utilisations
MX2024004906A (es) 2021-10-27 2024-05-06 Nestle Sa Metodo para producir productos similares a la leche.
IL311932A (en) 2021-10-27 2024-06-01 Soci?T? Des Produits Nestl? S A Method for producing milk like products
AU2022378939A1 (en) 2021-10-27 2024-04-11 Société des Produits Nestlé S.A. Method for producing milk like products
IL311933A (en) 2021-10-27 2024-06-01 Soci?T? Des Produits Nestl? S A A method for producing products such as milk
IL311931A (en) 2021-10-27 2024-06-01 Soci?T? Des Produits Nestl? S A Method for producing milk like products
EP4702127A1 (en) 2023-04-27 2026-03-04 Société des Produits Nestlé S.A. Method for producing milk like products
EP4455271A1 (en) 2023-04-27 2024-10-30 Société des Produits Nestlé S.A. Method for producing milk like products
EP4702126A1 (en) 2023-04-27 2026-03-04 Société des Produits Nestlé S.A. Method for producing milk like products
EP4455272A1 (en) 2023-04-27 2024-10-30 Société des Produits Nestlé S.A. Method for producing milk like products
WO2025228507A1 (en) 2024-04-29 2025-11-06 Société des Produits Nestlé S.A. Method for producing milk like products
WO2025228992A1 (en) 2024-04-29 2025-11-06 Société des Produits Nestlé S.A. Exosomes and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
US7347996B1 (en) * 2002-06-26 2008-03-25 Intevert International B.V. Avian cytokines, such as IL-12, comprising a p40 and/or p35 subunit and vaccines
US20080241188A1 (en) * 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes

Also Published As

Publication number Publication date
CN102056941A (zh) 2011-05-11
MX2010013693A (es) 2010-12-21
WO2009156367A1 (en) 2009-12-30
US20110110887A1 (en) 2011-05-12
EP2291397A1 (en) 2011-03-09
JP2011525519A (ja) 2011-09-22

Similar Documents

Publication Publication Date Title
BRPI0913216A2 (pt) uso de um herpesvírus recombinante de perus, e, herpesvírus recombinante de perus.
BRPI0921389A2 (pt) seringa de um só uso, de inutilização automática
BRPI0919014A2 (pt) composição fixadora de cabelo, e, uso de uma composição
BRPI1007018A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BRPI1012861A2 (pt) catalisador, e, uso do catalisador
BRPI1008906A2 (pt) composto, composição farmacêutica, e, uso de um composto.
BRPI1011916A2 (pt) uso de uma combinação de filtro uv, e, preparação cosmética.
BRPI0915134A2 (pt) composto, e, uso de um composto
BR112012002349A2 (pt) composto,e, uso do mesmo
BRPI0907453A2 (pt) Compostos, uso e preparação dos mesmos
BRPI0911351A2 (pt) estrutura de sent, e , prótese de válvula.
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0815709A2 (pt) composro, composição farmacêutica, e, uso de um composto.
BRPI0916930A2 (pt) Uso de 5-fluorocitosina como um fungicida.
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0920953A2 (pt) dispositivo de manutenção, e uso do mesmo.
BRPI0919216A2 (pt) poliuretano, e, uso de um poliuretano
BRPI0913188A2 (pt) moduladores de receptores 5-ht3, métodos de fabricação, e uso dos mesmos
BRPI1006996A2 (pt) composição, método e uso
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BRPI0913175A2 (pt) artigo antibalístico, e, uso do mesmo.
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0915473A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0918517A2 (pt) composto, composição farmacêutica, e, uso de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.